Led by Nobel laureate David Baker, researchers at UW Medicine's Institute for Protein Design have used AI to engineer ...

In this week's Pharma Pulse, DHL adds six dedicated cold chain air corridors linking Europe and North America to Asia, ...

Axoltis’ drug, NX210c, failed to meet clinical endpoints in a Phase II trial – but the company says other readouts are ...

Could a wearable robot help people with amyotrophic lateral sclerosis (ALS) walk farther? A new study from Toho University in ...

By Patrick Wingrove LONDON, Oct 15 (Reuters) - AstraZeneca has teamed up with artificial intelligence biotech company insitro ...

A ballot measure that would raise billions for health research is drawing some unlikely foes in a race that has already ...

The new funding boosts total NIH investment in the Access for All in ALS (ALL ALS) Consortium to $76.5 million.

The FDA has spent years trying to fit rare disease drug development into regulatory models that weren't designed for rare diseases. Its new Framework for Rare Disease Review suggests the agency is fin ...

The ALS Association today launched We Are Undeniable, a national campaign to help people living with ALS fight insurance ...

Spread the loveImagine a future where a debilitating disease, one that steals memories and identities, could be slowed, perhaps even halted, with just a few injections a year. For millions grappling ...

AI company unlocking causal human biology to systematically generate high-value therapeutics to treat grievous illness, today announced a worldwide exclusive research collaboration agreement with ...

After a physically and emotionally taxing 2025-26 season for Brandon Montour, he’s back strong with an “A” on his Kraken ...